Prognosis
U.S. Likely to Get Sanofi Vaccine First If It Succeeds
- Funding for research boosts U.S. push to reopen economy
- French company’s chief seeks to raise awareness in Europe
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
Americans will likely get Sanofi’s Covid-19 vaccine before the rest of the world if the French pharmaceutical giant can successfully deliver one.